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Abstract 
This is the first reported attempt to examine
the emboliogenic potential of cardiac myxoma
in patients with acute stroke through the mon-
itoring of microembolic signals (MES) by tran-
scranial  doppler.  A  43-year  old  woman  was
brought to the emergency department because
of  acute  onset  of  generalized  tonic-clonic
seizures and left hemiplegia. A CT scan of the
brain demonstrated a large acute infraction in
the territory of the right middle cerebral artery
(MCA) and another smaller one in the territo-
ry of the posterior cerebral artery on the same
side. Trans-cranial doppler (TCD) microemboli
monitoring  did  not  reveal  MES.
Transesophagial  echocardiography  (TEE)
identified a 5 cm left atrial mass, which was
highly  suspected  to  be  an  atrial  myxoma
attached  to  the  interatrial  septum  and  pro-
lapsed through the mitral valve. After the TEE
results were obtained, another TCD monitor-
ing was performed. Again, there were no MES
found in either of the MCAs. 
Our findings showed the absence of MES on
two consecutive TCD examinations, suggest-
ing a spontaneous occurrence, rather than the
permanent presence, of embolization, even in
the most acute phase of stroke. Thus, the ten-
dency of myxomas to spontaneously produce
multiple emboli emphasizes the need for the
surgical excision of myxomas.   
Introduction
Left atrial myxoma is a benign primary car-
diac  tumor  and  a  cause  of  embolic  stroke.
Primary tumors of the heart are rare and 75%
of those tumors are benign. Nearly half of the
benign heart tumors are myxomas, making it
the most common heart tumor. Although clas-
sified  as  benign  tumors,  myxomas  seem  to
grow and spread, but there is still debate as to
whether they metastase or fragments simply
embolize.
1 There  is  a  2:1  female  preponder-
ance and the age at onset is usually between
30-60 years. Although atrial myxoma is largely
sporadic,  at  least  7%  of  cases  are  familial.
Atrial myxomas have been estimated to cause
up to 0.5% of ischemic stroke.
2 Stroke appears
to be responsible for 80% of the neurological
presentations  of  myxomas,  and  only  40%  of
these have a typical pattern of cardioembolism
involving several vascular territories. Myxoma
usually causes ischemic stroke by embolism of
tumor or thrombus, but aneurismal dilations at
sites of earlier embolic vascular occlusion can
cause  intracerebral  or  subarachnoid  hemor-
rhage.
3
Cerebral imaging often demonstrates multi-
ple infracts suggestive of an embolic cause, but
in some cases it may show only small subcorti-
cal  ischemic  lesions,  as  seen  in  lacunar
infracts.
4 Transthoracic echocardiography has
approximately 90% sensitivity in the detection
of left atrial myxoma, while the sensitivity of
transesophageal examination is 100%. Trans-
esophageal  examination  is  also  preferred
because of its ability to detect other cardioe-
moblic  sources,  such  as  intracardiac  throm-
bus,  vegetations,  or  aortic  arch  plaque.
5
General or constitutional manifestations, such
as fatigue, fever, erythematous rash, arthral-
gia, myalgia, and weight loss, as well as labora-
tory abnormalities, such as anemia and elevat-
ed ESR and serum C reactive protein and glob-
ulin  levels,  have  been  observed  in  many
patients irrespective of the site and size of the
myxoma. The risk of recurrent myxoma is 1-3%
for sporadic cases, and it is usually attributed
to multifocal myxoma embolization or incom-
plete resection. Follow-up by echocardiography
is recommended.
1
It has not yet been established as to whether
transcranial Doppler (TCD) can be used as a
means to examine the emboliogenic potential
of  cardiac  myxoma  in  patients  with  acute
stroke.
Case Report 
A 43-year old woman from the Philippines
was brought to the emergency department of
Rambam  Medical  Center  in  Haifa,  Israel
because of acute onset of generalized tonic-
clonic  seizures  and  left  hemiplegia.  The
patient was generally healthy without any kind
of treatment or risk factors. No history of pre-
vious transient neurological deficit was report-
ed. On physical examination, she was found to
be in a stupor. Her vital signs were normal, and
cardiac exam revealed sinus rhythm without
heart  murmurs.  Neurological  examination
showed left central facial palsy, eye deviation
to the right, left hemiplegia, brisk deep tendon
reflexes,  and  extensor  plantar  reflex  on  the
left.  A  CT  scan  of  the  brain  on  admission
revealed a small old right parietal lobe infrac-
tion. Another CT was performed 24 hours later
and revealed a large acute infraction in the ter-
ritory of the right middle cerebral artery (MCA)
and another smaller one in the territory of the
posterior cerebral artery on the same side. The
erythrocyte sedimentation rate was 72 mm in
the first hour with no anemia. Blood coagula-
tion, lipid and homocysteine levels were nor-
mal. Treatment with phenytoin and plavix was
started.  Carotid  duplex,  including  common,
internal and external carotid arteries and ver-
tebral arteries, was normal. 
TCD (Pioneer, TC 8080, Viasys™, Nicolet)
microemboli monitoring was performed for 30
minutes,  with  both  MCAs  monitored.  No
microembolic  signals  (MES)  were  revealed.
Examination of cerebral blood flow velocities
was  normal.  Cardiac  holter  showed  a  sinus
rhythm average of 74 (62-119) without tachy or
brady-arrhythmia or conduction disturbances.
Transesophagial  echocardiography  (TEE)
identified a 5 cm left atrial mass, which was
highly  suspected  to  be  an  atrial  myxoma
(Figure 1) attached to the interatrial septum
and prolapsed through the mitral valve (with-
out  significant  LV  inflow  obstruction  in  the
supine position). After the TEE results were
obtained,  another  TCD  monitoring  was  per-
formed and continued this time for one hour.
Again, there were no MES found in either of
the MCAs. The myxoma was resected 23 days
after admission. Transthoracic echocardiogra-
phy  was  performed  three  days  after  surgery
and showed no evidence of residual myxoma or
atrial septal defect. The patient was referred
for further rehabilitation because of severe left
hemisyndrome. 
Discussion
One of the widely used applications of TCD
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useful information about possible sources of
embolism,  as  well  as  their  activity.  Acute
ischemic stroke, carotid stenosis, and cardiac
diseases are the most studied areas in the field
of MES monitoring. The significance of MES in
patients  with  cerebrovascular  diseases  has
been the subject of many studies. The short
Pubmed  literature  search  by  combination  of
MES and stroke retrieved 122 related items. 
The  first  line  of  research  is  devoted  to
revealing the prevalence and timing of MES
appearance  in  patients  with  acute  ischemic
stroke. It is now well established that MES is a
frequent  phenomenon  in  patients  with
ischemic stroke and that the amount of MES is
related to stroke onset, with the peak occurring
in the first hours and days after stroke.
6-10Many
other important studies have been devoted to
the  key  issue  of  using  the  presence  and
amount of MES as predictors of the short- and
long-term clinical outcomes during the index
event, as well as possible predictors of recur-
rent ischemic stroke.
11-17 Studies exploring the
correlation between prevalence and amount of
MES and the etiology of ischemic stroke can
also be found in the literature.
18-23
Another  line  of  research  estimates  the
impact  of  MES  in  both  symptomatic  and
asymptomatic carotid disease. In patients suf-
fering from carotid stenosis, the presence of
MES can be indicative of an unstable structure
of carotid plaque that is prone to be a source of
emboli. The existence of MES in patients with
carotid disease is also an important indicator
of the substantial danger of the first and recur-
rent cerebrovascular event.
24-29 Another area in
which  the  presence  of  MES  determines  the
increased  risk  of  peri-  and  post-procedural
complications  is  that  of  carotid  surgery  and
stenting. In both cases, the appearance of a
significant amount of MES reflects damage of
the plaque, resulting in multiple emboli with
neurological and cognitive impairment.
30-42
In cardiology, TCD is a reliable technique for
the  detection  of  MES  from  cardiac  embolic
sources, such as prosthetic cardiac valves,
43-45
aortic plaques,
18,46-48and atrial fibrillation.
20,23,49It
is also used as an especially sensitive tech-
nique for detecting right-to-left cardiac or pul-
monary shunts.
50-56 The microembolic signals
obtained  from  patients  with  artificial  heart
valves and during examinations for PFO detec-
tion have also been used as a model, alongside
other methods, in an attempt to differentiate
between  gaseous  and  solid  microemboli.
57-59
The results of MES monitoring may also be
found in some other clinical situations, where
their presence
60-65or absence
66-67helps us to bet-
ter  understand  the  role  of  embolism  in  the
development of the disease. Our case empha-
sizes that MES monitoring may be useful not
only in detecting the emboliogenic nature of
the disease, but also in exploring the precise
timing of embolization (i.e., either permanent,
as in the many clinical situations mentioned
above, or sporadic, as in our case). 
Although cardiac myxoma is a rare disease,
it should be considered in young patients with
stroke  and  elevated  ESR,  even  without  sys-
temic symptoms. There are no data in the liter-
ature about TCD monitoring in patients with
atrial  myxomas.  Our  findings  showed  the
absence  of  MES  on  two  consecutive  TCD
examinations,  suggesting  a  spontaneous
occurrence, rather than the permanent pres-
ence, of embolization, even in the most acute
phase  of  stroke.  These  data  are  compatible
with literature sources pointing to the simulta-
neous appearance of multiple emboli at differ-
ent  target  sites  in  patients  presenting  with
cardiac myxomas.
68 Another line of evidence
supporting  our  data  is  the  large  number  of
silent lesions commonly found in patients with
stroke and myxomas,
69 as in the case of the
patient presented here. Thus, it seems that in
many cases, despite silent embolic events, the
patient may remain clinically intact for years
until a symptomatic event occurs. The tenden-
cy  of  myxomas  to  spontaneously  produce
severe  and  multiple  emboli  emphasizes  the
need  for  the  surgical  excision  of  myxomas
when  possible  anticoagulation  seems  to  be
doubtful.   
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